Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 57

Sort by

Sort Order Select

Journal Articles

Dysregulation of the complement system in immune thrombocytopenia

Justin Oosterlee, Norá Veszeli, Jasmin Sabrina Rast, Helmuth Haslacher, Cihan Ay, Ingrid Pabinger, Zoltán Prohászka, Johanna Gebhart

Blood (2025) 146 (Supplement 1): 4823.

https://doi.org/10.1182/blood-2025-4823

Published: 2025

Journal Articles

Antidepressant agent use and risk of bleeding in patients with cancer: Results from the vienna CAT-bled study

Nikola Vladic, Cornelia Englisch, Florian Moik, Daniel Steiner, Vincent Sunder-Plassmann, Angelika Starzer, Anna Berghoff, Matthias Preusser, Ingrid Pabinger, Cihan Ay

Blood (2025) 146 (Supplement 1): 6636.

https://doi.org/10.1182/blood-2025-6636

Published: 2025

Journal Articles

From efficacy to experience: 52-week patient-reported outcomes with Mim8 in adolescents and adults with hemophilia A with or without inhibitors (FRONTIER2)

Cedric Hermans, Sanjay Ahuja, Hazza Alzahrani, Cihan Ay, Peter Kampmann, Samya Obaji, Sophie Susen, Ciprian Tomuleasa, Lize van Vulpen, Amalie Rhode Høgh Nielsen, Ilgiz Rakhmatullin, Carmen Escuriola-Ettingshausen

Blood (2025) 146 (Supplement 1): 540.

https://doi.org/10.1182/blood-2025-540

Published: 2025

Journal Articles

Mim8 prophylaxis in adults and adolescents with hemophilia A: 52-week efficacy and safety outcomes from the phase 3 FRONTIER2 study

Steven Lentz, Aby Abraham, Cihan Ay, Anthony Chan, Víctor Jiménez-Yuste, Johannes Oldenburg, Maria Elisa Mancuso, Johnny Mahlangu, Tadashi Matsushita, Lize van Vulpen, Renchi Yang, Amalie Rhode Høgh Nielsen, Ilgiz Rakhmatullin, Pratima Chowdary

Blood (2025) 146 (Supplement 1): 537.

https://doi.org/10.1182/blood-2025-537

Published: 2025

Journal Articles

A FXIa-modified clot waveform analysis for estimation of factor VIII level and emicizumab concentration in hemophilia A

Oliver Königsbrügge, Atsuo Suzuki, Daniel Kraemmer, Nobuaki Suzuki, Ingrid Pabinger, Cihan Ay, Tadashi Matsushita

Blood (2025) 146 (Supplement 1): 3065.

https://doi.org/10.1182/blood-2025-3065

Published: 2025

Journal Articles

Blood group o and a lower endogenous thrombin potential are associated with increased risk for future bleeding after hemostatic challenges in bleeding disorder of unknown cause

Tim Dreier, Dino Mehic, Justin Oosterlee, Cihan Ay, Ingrid Pabinger, Johanna Gebhart

Blood (2025) 146 (Supplement 1): 1300.

https://doi.org/10.1182/blood-2025-1300

Published: 2025

Journal Articles

Effects of serum vitamin d on platelet function in primary immune thrombocytopenia

Justin Oosterlee, Dino Mehic, Tim Dreier, Alexander Tolios, Beate Eichelberger, Helmuth Haslacher, Cihan Ay, Ingrid Pabinger, Johanna Gebhart

Blood (2025) 146 (Supplement 1): 6576.

https://doi.org/10.1182/blood-2025-6576

Published: 2025

Journal Articles

Real world data on the use of thrombopoietin receptor agonists in patients after allogeneic hematopoietic stem cell transplantation

Julia Cserna, Lina Zoe Ruesing, Hanna Knaus, Philipp Wohlfarth, Armin Bumberger, Dino Mehic, Justin Oosterlee, Axel Schulenburg, Margit Mitterbauer, Ingrid Pabinger, Cihan Ay, Werner Rabitsch, Johanna Gebhart

Blood (2025) 146 (Supplement 1): 4214.

https://doi.org/10.1182/blood-2025-4214

Published: 2025

Journal Articles

Air pollution and venous thromboembolism

Ingrid Pabinger, Cihan Ay

Blood (2025) 145 (10): 1003–1004.

https://doi.org/10.1182/blood.2024027502

Published: 2025

Journal Articles

Saliva of persons with hemophilia A triggers coagulation via extrinsic tenase complexes

Johannes Thaler, Carla Tripisciano, Daniel Kraemmer, Chi Hau, Nazanin Samadi, Wolfram Ruf, Ingrid Pabinger, Paul Knoebl, Rienk Nieuwland, Cihan Ay

Blood (2024) 144 (25): 2666–2677.

https://doi.org/10.1182/blood.2024025093

Published: 2024

Includes: Supplemental data

Journal Articles

Bleeding events in patients with cancer: incidence, risk factors, and impact on prognosis in a prospective cohort study

Cornelia Englisch, Florian Moik, Daniel Steiner, Angelika M. Starzer, Anna S. Berghoff, Matthias Preusser, Ingrid Pabinger, Cihan Ay

Blood (2024) 144 (22): 2349–2359.

https://doi.org/10.1182/blood.2024025362

Published: 2024

Includes: Supplemental data

Journal Articles

Discriminating Factors of Bleeding Disorder of Unknown Cause in a Cohort of Patients with Mild to Moderate Bleeding Disorders

Tim Dreier, Dino Mehic, Justin Oosterlee, Jasmin Sabrina Rast, Cihan Ay, Ingrid Pabinger, Johanna Gebhart

Blood (2024) 144 (Supplement 1): 1218.

https://doi.org/10.1182/blood-2024-204765

Published: 2024

Journal Articles

Mim8 Prophylaxis Beyond Bleeding: Investigating Multifaceted, Patient-Reported Outcomes for Hemophilia A in the FRONTIER2 Study

Cedric Hermans, Cihan Ay, Carmen Escuriola, Peter Kampmann, Rikke Medom Meldgaard, Ilgiz Rakhmatullin, Ciprian Tomuleasa, Lize Fie Ditteke van Vulpen, Michael Wang, Irena Woźnica-Karczmarz, Sophie Susen

Blood (2024) 144 (Supplement 1): 1212.

https://doi.org/10.1182/blood-2024-198395

Published: 2024

Journal Articles

A Phase Ia Study of VGA039, a Protein S-Targeting Monoclonal Antibody, in Individuals with Von Willebrand Disease Demonstrates Concentration-Dependent Increases in Thrombin Generation for Reducing Bleeding

Carolyn M Millar, Priyanka Raheja, Allison P Wheeler, Shrinath Kshirsagar, Christian Schoergenhofer, Nicoletta C Machin, Cihan Ay, Almudena Tercero, Hayley Lane, Christopher J Horvath, Sandip Panicker, Gary Patou, Benjamin Kim, Savita Rangarajan

Blood (2024) 144 (Supplement 1): 3981.

https://doi.org/10.1182/blood-2024-208020

Published: 2024

Journal Articles

Rondaptivon Pegol (BT200) to Correct Thrombocytopenia in a Peri-Interventional Setting in Type 2B Von Willebrand Disease (VWD)

Miriam Moser, Cihan Ay, Christian Schoergenhofer, James C Gilbert, Shuhao Zhu, Bernd Jilma

Blood (2024) 144 (Supplement 1): 3984.

https://doi.org/10.1182/blood-2024-202611

Published: 2024

Journal Articles

Impact of Blood Group O and Von Willebrand Factor on Bleeding Severity in Patients with Von Willebrand Disease and Bleeding Disorder of Unknown Cause

Dino Mehic, Daniel Kraemmer, Jasmin Sabrina Rast, Silvia Koder, Michelle Fuchs, Helmuth Haslacher, Peter Quehenberger, Cihan Ay, Ingrid Pabinger, Johanna Gebhart

Blood (2023) 142 (Supplement 1): 1249.

https://doi.org/10.1182/blood-2023-185843

Published: 2023

Journal Articles

Utility of the Platelet Function Analyzer (PFA-100) in Patients with Bleeding Disorder of Unknown Cause

Dino Mehic, Jasmin Sabrina Rast, Michelle Fuchs, Alexander Tolios, Beate Eichelberger, Alexandra Kaider, Cihan Ay, Ingrid Pabinger, Johanna Gebhart

Blood (2023) 142 (Supplement 1): 3965.

https://doi.org/10.1182/blood-2023-185756

Published: 2023

Journal Articles

High Risk of Thrombosis in a Prospective Cohort of Adults with Primary Immune Thrombocytopenia

Jasmin Sabrina Rast, Theresa Schramm, Dino Mehic, Michelle Fuchs, Michael Fillitz, Cihan Ay, Ingrid Pabinger, Johanna Gebhart

Blood (2023) 142 (Supplement 1): 1208.

https://doi.org/10.1182/blood-2023-185866

Published: 2023

Journal Articles

The von Willebrand factor–binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia A

Cihan Ay, Katarina D. Kovacevic, Daniel Kraemmer, Christian Schoergenhofer, Georg Gelbenegger, Christa Firbas, Peter Quehenberger, Petra Jilma-Stohlawetz, James C. Gilbert, Shuhao Zhu, Martin Beliveau, Franz Koenig, Alfonso Iorio, Bernd Jilma, Ulla Derhaschnig, Ingrid Pabinger

Blood (2023) 141 (10): 1147–1158.

https://doi.org/10.1182/blood.2022016571

Published: 2023

Includes: Supplemental data

Journal Articles

Repeated Testing Unfolds the Challenge of Diagnosing Von Willebrand Disease: Longitudinal Data from the Vienna Bleeding Biobank

Dino Mehic, Daniel Kraemmer, Alexander Tolios, Julia Bücheler, Peter Quehenberger, Cihan Ay, Ingrid Pabinger, Johanna Gebhart

Blood (2022) 140 (Supplement 1): 8433–8434.

https://doi.org/10.1182/blood-2022-158959

Published: 2022

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Dysregulation of the complement system in immune thrombocytopenia

Antidepressant agent use and risk of bleeding in patients with cancer: Results from the vienna CAT-bled study

From efficacy to experience: 52-week patient-reported outcomes with Mim8 in adolescents and adults with hemophilia A with or without inhibitors (FRONTIER2)

Mim8 prophylaxis in adults and adolescents with hemophilia A: 52-week efficacy and safety outcomes from the phase 3 FRONTIER2 study

A FXIa-modified clot waveform analysis for estimation of factor VIII level and emicizumab concentration in hemophilia A

Blood group o and a lower endogenous thrombin potential are associated with increased risk for future bleeding after hemostatic challenges in bleeding disorder of unknown cause

Effects of serum vitamin d on platelet function in primary immune thrombocytopenia

Real world data on the use of thrombopoietin receptor agonists in patients after allogeneic hematopoietic stem cell transplantation

Air pollution and venous thromboembolism

Saliva of persons with hemophilia A triggers coagulation via extrinsic tenase complexes

Bleeding events in patients with cancer: incidence, risk factors, and impact on prognosis in a prospective cohort study

Discriminating Factors of Bleeding Disorder of Unknown Cause in a Cohort of Patients with Mild to Moderate Bleeding Disorders

Mim8 Prophylaxis Beyond Bleeding: Investigating Multifaceted, Patient-Reported Outcomes for Hemophilia A in the FRONTIER2 Study

A Phase Ia Study of VGA039, a Protein S-Targeting Monoclonal Antibody, in Individuals with Von Willebrand Disease Demonstrates Concentration-Dependent Increases in Thrombin Generation for Reducing Bleeding

Rondaptivon Pegol (BT200) to Correct Thrombocytopenia in a Peri-Interventional Setting in Type 2B Von Willebrand Disease (VWD)

Impact of Blood Group O and Von Willebrand Factor on Bleeding Severity in Patients with Von Willebrand Disease and Bleeding Disorder of Unknown Cause

Utility of the Platelet Function Analyzer (PFA-100) in Patients with Bleeding Disorder of Unknown Cause

High Risk of Thrombosis in a Prospective Cohort of Adults with Primary Immune Thrombocytopenia

The von Willebrand factor–binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia A

Repeated Testing Unfolds the Challenge of Diagnosing Von Willebrand Disease: Longitudinal Data from the Vienna Bleeding Biobank

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only